MedPath

The efficacy of radioguided occult lesion localisation (ROLL) versus wire guided lesion localisation (WGL) in breast conserving surgery for non palpable breast cancer: a randomised controlled trial

Phase 3
Completed
Conditions
breast cancer
breast carcinoma
10006291
10006295
Registration Number
NL-OMON35161
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
316
Inclusion Criteria

Patients with a non palpable breast carcinoma who are eligible for a lumpectomy and sentinel node biopsy

Exclusion Criteria

- Pregnant or lactating patients
- Patients with a multi focal carcinoma
- Patients with ductal carcinoma in situ (DCIS) or a lobular carcinoma in situ (LCIS) without invasive growth

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1) The percentage of tumour-free margins (invasive and in situ) after the ROLL<br /><br>vs. the WGL procedure (i.e. oncologic outcome).<br /><br>2) The volume and maximum diameter of the lumpectomy of ROLL vs. WGL (i.e.<br /><br>cosmetic outcome).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1) The cost-effectiveness of ROLL vs. WGL (i.e. operation time, radiological<br /><br>localisation time, hospital stay and materials).<br /><br>2) The degree of difficulty of the radiological and surgical procedure.<br /><br>3) The degree of patient (dis)comfort of the radiological procedure ROLL vs.<br /><br>WGL (number of procedures, pain, complications).<br /><br>4) The success rate of the sentinel node procedure (visualisation and<br /><br>localisation).</p><br>
© Copyright 2025. All Rights Reserved by MedPath